Stocks Industrials STEK
OTC · IndustrialsStemtech Corp (STEK)
Stemtech Corp brought in $2.4M of revenue over the twelve months to June 30, 2026, down 38.6% from a year earlier. It posted a net loss of $3.8M. In fiscal 2025 capital spending exceeded operating cash flow by $483.6K. At June 30, 2026 it held $246.8K in cash against $4.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch STEK in 60 secondsWhat Stemtech Corp does
Stemtech Corp is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on OTC under the ticker STEK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.9M | -$4M | -$0.02 | -$483.6K |
| 2024 | $5.1M | -$3.8M | -$0.03 | -$601.2K |
| 2023 | $4.9M | -$5.4M | -$0.07 | -$2M |
| 2022 | $4.6M | -$8.5M | -$0.19 | n/a |
| 2021 | $4.3M | -$7.1M | -$0.20 | n/a |
| 2021 | $4.4M | -$916.7K | -$0.11 | -$278.3K |
Full financial statements: income, balance sheet and cash flow
Where STEK ranks in Industrials
Latest SEC filings
What Stemtech Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 9.8% to $629.3K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- June 22, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 47% to $463K versus the same quarter last year; diluted EPS $0.00 versus -$0.01.
- May 29, 2026Annual report 10-K · period to December 31, 2025Revenue fell 43% to $2.9M versus the prior year; diluted EPS -$0.02 versus -$0.03.
- May 14, 2026Late quarterly report notice (amended) NT 10-Q/A
- May 14, 2026Late quarterly report notice NT 10-Q
- March 31, 2026Late annual report notice NT 10-K
- November 19, 2025Quarterly report 10-Q · period to September 30, 2025Revenue fell 17% to $852.3K versus the same quarter last year; diluted EPS -$0.01 versus -$0.01.
- November 14, 2025Late quarterly report notice NT 10-Q
- August 19, 2025
- August 14, 2025Late quarterly report notice NT 10-Q
Questions about STEK
What does Stemtech Corp do?
Stemtech Corp is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on OTC under the ticker STEK.
Is Stemtech Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.8M on revenue of $2.4M.
How much revenue does Stemtech Corp make?
Over the twelve months to June 30, 2026 Stemtech Corp reported revenue of $2.4M. That is 38.6% less than a year earlier.
When did Stemtech Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare STEK with
Follow STEK
Get an email when Stemtech Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow STEK: get an email when it filesWhere the numbers come from
Financial figures are the values Stemtech Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.